TITLE

Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey

AUTHOR(S)
Gençer, Serap; Ak, Öznur; Benzonana, Nur; Ayşe Bat rel; Özer, Serdar
PUB. DATE
January 2002
SOURCE
Annals of Clinical Microbiology & Antimicrobials;2002, Vol. 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Pseudomonas aeruginosa is the third most common pathogen responsible for nosocomial infections and the prevalence of multiple resistant isolates has been increasing. Ninetynine clinical isolates were studied in order to assess the current levels of susceptibility and crossresistances of widely used antipseudomonal antibiotics against P. aeruginosa and to determine some resistance mechanisms by phenotypic methods. Methods: MICs of isolates for nine antipseudomonal antibiotics were determined by the E test method. Results: Thirty-six percent of isolates were resistant to more than one group of antibiotics. The rates of susceptible isolates were ciprofloxacin 75%, amikacin 73%, ceftazidime 65%, meropenem 63%, imipenem 63%, piperacillin/tazobactam 60%, cefoperazone/sulbactam 59%, cefepime 54% and tobramycin 44%. The majority of carbapenem resistant isolates were susceptible to ciprofloxacin and amikacin. Conclusion: Ciprofloxacin seems to be the most active agent against P. aeruginosa followed by amikacin in our unit. The usefulness of combinations of these antibiotics and β-lactams should be tested in treating multi-drug resistant P. aeruginosa.
ACCESSION #
28781404

 

Related Articles

  • Mortality related to Verona Integron-encoded Metallo-β-lactamase-positive Pseudomonas aeruginosa: assessment by a novel clinical tool. Persoon, Marjolein C.; Voor in 't holt, Anne F.; van Meer, Maurits P. A.; Bokhoven, Karen C.; Gommers, Diederik; Vos, Margreet C.; Severin, Juliëtte A. // Antimicrobial Resistance & Infection Control;6/19/2019, Vol. 8 Issue 1, pN.PAG 

    Background: Verona Integron-encoded Metallo-β-lactamase-positive Pseudomonas aeruginosa (VIM-PA) can cause nosocomial infections and may be responsible for increased mortality. Multidrug resistance in VIM-PA complicates treatment. We aimed to assess the contribution of VIM-PA to mortality in...

  • Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary. Szabó, Dora; Szentandrássy, Julia; Juhász, Zsuzsa; Katona, Katalin; Nagy, Károly; Rókusz, László // Annals of Clinical Microbiology & Antimicrobials;2008, Vol. 7, Special section p1 

    Introduction: Pseudomonas aeruginosa and Acinetobacter baumanii are important nosocomial pathogens with wide intrinsic resistance. However, due to the dissemination of the acquired resistance mechanisms, such as extended-spectrum beta-lactamase (ESBL) and metallo beta-lactamase (MBL) production,...

  • Drug-resistant pathogen found. Investor's Business Daily // Investors Business Daily;8/13/2014, pA02 

    A new antibiotic-resistant, virulent strain of the pathogen Pseudomonas aeruginosa has been found, said a research team led by a member of the Louis Stokes Cleveland Dept. of Veterans Affairs Medical Center. The drug-impervious strain was 1st discovered in an Ohio care facility in a 69-year-old...

  • Dutch Guideline for Preventing Nosocomial Transmission of Highly Resistant Microorganisms (HRMO). Kluytmans-VandenBergh, M. F. O.; Kluytmans, J. A. J. W.; Voss, A. // Infection;Oct2005, Vol. 33 Issue 5/6, p309 

    Hospitals are faced with the increasingly rapid emergence and dissemination of antimicrobial–resistant microorganisms. US and European guidelines on the prevention of antimicrobial resistance in hospitals were, until recently, mainly directed at methicillin–resistant Staphylococcus...

  • Induction of human plasmablasts during infection with antibiotic-resistant nosocomial bacteria. Band, Victor I.; Ibegbu, Chris; Kaur, Surinder Pal; Cagle, Stephanie M.; Trible, Ronald; Jones, Crystal L.; Wang, Yun F.; Kraft, Colleen S.; Ray, Susan M.; Wrammert, Jens; Weiss, David S. // Journal of Antimicrobial Chemotherapy (JAC);Jul2014, Vol. 69 Issue 7, p1830 

    Objectives Nosocomial pathogens such as Acinetobacter baumannii are a growing public health threat, due in part to their increasing resistance to antibiotics. Since some strains are resistant to all available antibiotics, novel therapies are urgently needed. Plasmablasts are short-lived B cells...

  • Modelling Co-Infection of the Cystic Fibrosis Lung by Pseudomonas aeruginosa and Burkholderia cenocepacia Reveals Influences on Biofilm Formation and Host Response. Bragonzi, Alessandra; Farulla, Ilaria; Paroni, Moira; Twomey, Kate B.; Pirone, Luisa; Lorè, Nicola Ivan; Bianconi, Irene; Dalmastri, Claudia; Ryan, Robert P.; Bevivino, Annamaria // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    The Gram-negative bacteria Pseudomonas aeruginosa and Burkholderia cenocepacia are opportunistic human pathogens that are responsible for severe nosocomial infections in immunocompromised patients and those suffering from cystic fibrosis (CF). These two bacteria have been shown to form biofilms...

  • Appropriate antibacterial therapy is crucial in the management of Pseudomonas aeruginosa infections.  // Drugs & Therapy Perspectives;Oct2007, Vol. 23 Issue 10, p14 

    The article discusses the management of Pseudomonas (P.) aeruginosa infections. It is advised that P. aeruginosa, a common nosocomial infection, be identified and treated early with empirical agents involving two antibacterial drugs. It is stated that outbreaks could be prevented through...

  • The relationship between the daily dosage of the carbapenem meropenem (MEPM) and MEPM-resistant Pseudomonas aeruginosa. Hiroko Kondo; Atsuko Nabeshima; Masako Shimoda; Kouzaburo Yamaji; Takahiko Horiuchi; Nobuyuki Shimono; Hideyuki Ikematsu // Journal of Infection & Chemotherapy (Springer Science & Business;Jun2008, Vol. 14 Issue 3, p219 

    Abstract   Pseudomonas aeruginosa is a pathogen which is known to be responsible for nosocomial infection. The appropriate use of antibiotics has become important for preventing the spread of drug-resistant P. aeruginosa. In Hara-doi Hospital, two carbapenem antibiotics, imipenem (IPM) and...

  • An outbreak and isolation of drug-resistant Pseudomonas aeruginosa at Niigata University Hospital, Japan. Ritsuko Satoh; Hiroki Tsukada; Yoshinari Tanabe; Yukiko Tamura; Tatsuo Yamamoto; Misao Takano; Kyoko Ozaki; Takashi Tamura; Fumitake Gejyo // Journal of Infection & Chemotherapy (Springer Science & Business;Aug2008, Vol. 14 Issue 4, p325 

    Abstract   Pseudomonas aeruginosa is an opportunistic pathogen that causes disease in patients with impaired host defenses; it is often a cause of life-threatening nosocomial infection in critically ill and immunocompromised patients. An increase in the prevalence of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics